These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo biodistribution of dendrimers and dendrimer nanocomposites -- implications for cancer imaging and therapy. Khan MK; Nigavekar SS; Minc LD; Kariapper MS; Nair BM; Lesniak WG; Balogh LP Technol Cancer Res Treat; 2005 Dec; 4(6):603-13. PubMed ID: 16292880 [TBL] [Abstract][Full Text] [Related]
3. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Balogh L; Nigavekar SS; Nair BM; Lesniak W; Zhang C; Sung LY; Kariapper MS; El-Jawahri A; Llanes M; Bolton B; Mamou F; Tan W; Hutson A; Minc L; Khan MK Nanomedicine; 2007 Dec; 3(4):281-96. PubMed ID: 17962085 [TBL] [Abstract][Full Text] [Related]
4. gamma-Glutamyl PAMAM dendrimer as versatile precursor for dendrimer-based targeting devices. Uehara T; Ishii D; Uemura T; Suzuki H; Kanei T; Takagi K; Takama M; Murakami M; Akizawa H; Arano Y Bioconjug Chem; 2010 Jan; 21(1):175-81. PubMed ID: 20000792 [TBL] [Abstract][Full Text] [Related]
6. Biodistribution, pharmacokinetics, and toxicity of dendrimer-coated iron oxide nanoparticles in BALB/c mice. Salimi M; Sarkar S; Fathi S; Alizadeh AM; Saber R; Moradi F; Delavari H Int J Nanomedicine; 2018; 13():1483-1493. PubMed ID: 29559777 [TBL] [Abstract][Full Text] [Related]
7. Analysis of biotinylated generation 4 poly(amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier. Hemmer R; Hall A; Spaulding R; Rossow B; Hester M; Caroway M; Haskamp A; Wall S; Bullen HA; Morris C; Haik KL Molecules; 2013 Sep; 18(9):11537-52. PubMed ID: 24048286 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of chromosomal aberrations induced by Tassano M; Oddone N; Fernández M; Porcal W; García MF; Martínez-López W; Benech JC; Cabral P Int J Radiat Biol; 2018 Jul; 94(7):664-670. PubMed ID: 29775404 [TBL] [Abstract][Full Text] [Related]
9. Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier. Yan C; Gu J; Hou D; Jing H; Wang J; Guo Y; Katsumi H; Sakane T; Yamamoto A Drug Dev Ind Pharm; 2015 Apr; 41(4):617-22. PubMed ID: 24564798 [TBL] [Abstract][Full Text] [Related]
11. Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats. Boyd BJ; Kaminskas LM; Karellas P; Krippner G; Lessene R; Porter CJ Mol Pharm; 2006; 3(5):614-27. PubMed ID: 17009860 [TBL] [Abstract][Full Text] [Related]
12. Carboxymethyl chitosan-poly(amidoamine) dendrimer core-shell nanoparticles for intracellular lysozyme delivery. Zhang X; Zhao J; Wen Y; Zhu C; Yang J; Yao F Carbohydr Polym; 2013 Nov; 98(2):1326-34. PubMed ID: 24053810 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody. Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971 [TBL] [Abstract][Full Text] [Related]
14. Binding free energy calculations using MMPB/GBSA approaches for PAMAM-G4-drug complexes at neutral, basic and acid pH conditions. Martínez-Muñoz A; Bello M; Romero-Castro A; Rodríguez-Fonseca RA; Rodrigues J; Sánchez-Espinosa VA; Correa-Basurto J J Mol Graph Model; 2017 Sep; 76():330-341. PubMed ID: 28759825 [TBL] [Abstract][Full Text] [Related]
15. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers. Kaminskas LM; Boyd BJ; Karellas P; Krippner GY; Lessene R; Kelly B; Porter CJ Mol Pharm; 2008; 5(3):449-63. PubMed ID: 18393438 [TBL] [Abstract][Full Text] [Related]
16. Effects of Polyamidoamine Dendrimers on a 3-D Neurosphere System Using Human Neural Progenitor Cells. Zeng Y; Kurokawa Y; Zeng Q; Win-Shwe TT; Nansai H; Zhang Z; Sone H Toxicol Sci; 2016 Jul; 152(1):128-44. PubMed ID: 27125967 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer. Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021 [TBL] [Abstract][Full Text] [Related]
18. Development of 99mTc(CO)₃-dendrimer-FITC for cancer imaging. Tassano MR; Audicio PF; Gambini JP; Fernandez M; Damian JP; Moreno M; Chabalgoity JA; Alonso O; Benech JC; Cabral P Bioorg Med Chem Lett; 2011 Sep; 21(18):5598-601. PubMed ID: 21778055 [TBL] [Abstract][Full Text] [Related]
19. Capillary electrophoresis of poly(amidoamine) dendrimers: from simple derivatives to complex multifunctional medical nanodevices. Shi X; Majoros IJ; Baker JR Mol Pharm; 2005; 2(4):278-94. PubMed ID: 16053331 [TBL] [Abstract][Full Text] [Related]
20. Naked Poly(amidoamine) Dendrimer Nanoparticles Exhibit Intrinsic Embryotoxicity During the Early Stages of Normal Development. Kheraldine H; Gupta I; Alhussain H; Jabeen A; Akhtar S; Al Moustafa AE; Rachid O J Biomed Nanotechnol; 2020 Oct; 16(10):1454-1462. PubMed ID: 33422157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]